FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells

L-M Sturla1, A E Merrick, S A Burchill

  • 1Candlelighter's Children's Cancer Research Laboratory, Cancer Research UK Clinical Centre, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.

Insights

A novel Fibroblast Growth Factor Receptor 3 (FGFR3) variant, FGFR3IIIS, was identified. This variant may inhibit FGFR3-induced growth arrest, potentially contributing to cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Fibroblast Growth Factor Receptor 3 (FGFR3) is a tyrosine kinase receptor involved in cell growth and differentiation.
  • Ligand binding specificity is determined by alternative splicing of exons IIIb and IIIc in the FGFR3 Ig-like domain III.
  • Aberrant FGFR3 signaling is implicated in various cancers.

Purpose of the Study:

  • To identify and characterize novel FGFR3 variants.
  • To investigate the functional role of the newly identified FGFR3IIIS variant.
  • To explore the potential contribution of FGFR3IIIS to malignant phenotypes.

Main Methods:

  • Reverse transcriptase polymerase chain reaction (RT-PCR) for variant identification.
  • Analysis of protein expression in membrane and soluble cell fractions.
  • In vitro studies using antisense technology to assess functional impact.

Main Results:

  • A novel FGFR3IIIc variant, FGFR3IIIS, was identified, predominantly expressed in tumors.
  • FGFR3IIIS produces a novel, in-frame protein coexpressed with FGFR3IIIc.
  • Knockout of FGFR3IIIS demonstrated in vitro growth inhibition, suggesting a dominant-negative function.

Conclusions:

  • Alternative splicing of FGFR3 Ig-domain III generates receptor diversity.
  • FGFR3IIIS may play a regulatory role in FGF and FGFR trafficking and function.
  • FGFR3IIIS is a potential contributor to the development of a malignant phenotype.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...